stockrow
Monday 9 November 2026
Export LTGO’s income statement to Excel — free account
Latigo Biotherapeutics Inc
LTGO
13.24
0.64
+5.08%
Follow LTGO
Alert me
| Dec '25 | |
|---|---|
| 0.00% | |
| 0.00% | |
Return on Tangible Assets |
0.00% |
Free Cash Flow per Share |
0.00 |
Cash per Share |
0.00 |
Shareholders Equity per Share |
0.00 |
Interest Debt per Share |
0.00 |
Book value per Share |
0.00 |
| Other line items | |
Debt/Assets |
0.00% |
Operating CF/Net income |
0.00 |
Intangible Assets out of Total Assets |
0.00 |
Revenue per Share |
0.00 |
Operating CF per Share |
0.00 |
Capex per Share |
0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026